HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What Did US Consumers Buy With Stimulus Checks? E.l.f. Beauty Products, For One Thing

Executive Summary

In the current economy, e.l.f.’s value messaging is resonating with new consumers, contributing to an 8% jump in its fiscal 2021 first-quarter sales. The company expects continued volatility, but is optimistic about its robust digital game, growing skin-care clout and a newly announced partnership with Alicia Keys that it says will yield much more than “just another celebrity beauty line.”

You may also be interested in...



E.l.f. Beauty Sales Jump 50% With Makeup Rebound, Online Gaming Push

Gen Z-focused E.l.f. Beauty Inc. booked 50% net sales growth in its fiscal 2022 first quarter with continued improvisation across social media platforms where mainstream players still hesitate to venture.

Coty To Improve Fragrance Sustainability; Ulta Bringing Beauty Into Loop; Cosmetics News In Brief

Coty and Ulta Beauty announce sustainability initiatives, Whole Foods declares 2021 clean beauty trends, and e.l.f. Cosmetics prepares to launch a Chipotle burrito-inspired makeup collection.

E.l.f. Priming Alicia Keys Brand, Fans For Global Launch: ‘The World Is Craving A Brand With Soul’

Coming off its seventh consecutive quarter of net sales growth, E.l.f. expects big things from Keys Soulcare, its third and loftiest brand that is building an online community ahead of initial product launches and a global debut planned for the new year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel